• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个用于描述快速抗抑郁治疗反应时程的计算模型。

A computational model to characterize the time-course of response to rapid antidepressant therapies.

机构信息

Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.

Faculty of Computer Science, Dalhousie University, Halifax, Nova Scotia, Canada.

出版信息

PLoS One. 2024 Feb 2;19(2):e0297708. doi: 10.1371/journal.pone.0297708. eCollection 2024.

DOI:10.1371/journal.pone.0297708
PMID:38306352
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10836665/
Abstract

Our objective is to propose a method capable of disentangling the magnitude, the speed, and the duration or decay rate of the time course of response to rapid antidepressant therapies. To this end, we introduce a computational model of the time course of response to a single treatment with a rapid antidepressant. Numerical simulation is used to evaluate whether model parameters can be accurately estimated from observed data. Finally, we compare our computational modelling-based approach with linear mixed effects modelling in terms of their ability to detect changes in the magnitude and time-course of response to rapid antidepressant therapies in simulated randomized trials. Simulation experiments show that the parameters of our computational model can be accurately recovered using nonlinear least squares. Parameter estimation accuracy is stable over noise levels reaching as high as 25% of the true antidepressant effect magnitude. Comparison of our approach to mixed effects modelling using simulated randomized controlled trial data demonstrates an inability of linear mixed models to disentangle effect magnitude and time course, while our computational model accurately separates these response components. Our modelling approach may accurately identify the (A) magnitude, (B) speed, and (C) durability or decay rate of response to rapid antidepressant therapies. Future studies should fit this model to data from real clinical trials, and use resulting parameter estimates to uncover predictors and causes of different elements of the temporal course of antidepressant response.

摘要

我们的目标是提出一种能够区分快速抗抑郁治疗反应时程的幅度、速度和持续时间或衰减率的方法。为此,我们引入了一个快速抗抑郁治疗反应时程的计算模型。数值模拟用于评估模型参数是否可以从观测数据中准确估计。最后,我们比较了我们基于计算建模的方法与线性混合效应建模在模拟随机试验中检测快速抗抑郁治疗反应幅度和时程变化的能力。模拟实验表明,我们的计算模型的参数可以使用非线性最小二乘法准确恢复。参数估计的准确性在噪声水平达到真实抗抑郁效应幅度的 25%时仍然稳定。使用模拟随机对照试验数据比较我们的方法与混合效应建模表明,线性混合模型无法区分效应幅度和时程,而我们的计算模型可以准确分离这些反应成分。我们的建模方法可以准确识别快速抗抑郁治疗反应的(A)幅度、(B)速度和(C)耐久性或衰减率。未来的研究应该将该模型拟合到真实临床试验数据中,并使用所得的参数估计值来揭示抗抑郁反应时间过程中不同元素的预测因子和原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3240/10836665/2f816967677e/pone.0297708.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3240/10836665/fb1aec58b895/pone.0297708.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3240/10836665/1c94e8920cab/pone.0297708.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3240/10836665/ffdae08a1188/pone.0297708.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3240/10836665/2f816967677e/pone.0297708.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3240/10836665/fb1aec58b895/pone.0297708.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3240/10836665/1c94e8920cab/pone.0297708.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3240/10836665/ffdae08a1188/pone.0297708.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3240/10836665/2f816967677e/pone.0297708.g004.jpg

相似文献

1
A computational model to characterize the time-course of response to rapid antidepressant therapies.一个用于描述快速抗抑郁治疗反应时程的计算模型。
PLoS One. 2024 Feb 2;19(2):e0297708. doi: 10.1371/journal.pone.0297708. eCollection 2024.
2
Comparative effectiveness of continuation and maintenance treatments for persistent depressive disorder in adults.成人持续性抑郁症延续治疗和维持治疗的比较效果
Cochrane Database Syst Rev. 2019 May 20;5(5):CD012855. doi: 10.1002/14651858.CD012855.pub2.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Antidepressants for people with epilepsy and depression.用于癫痫伴抑郁症患者的抗抑郁药。
Cochrane Database Syst Rev. 2014 Dec 3;2014(12):CD010682. doi: 10.1002/14651858.CD010682.pub2.
5
A systematic review of comparative efficacy of treatments and controls for depression.系统评价抑郁症治疗和对照措施的疗效比较。
PLoS One. 2012;7(7):e41778. doi: 10.1371/journal.pone.0041778. Epub 2012 Jul 30.
6
Bayesian modelling and ROC analysis to predict placebo responders using clinical score measured in the initial weeks of treatment in depression trials.使用抑郁症试验治疗初期测得的临床评分,通过贝叶斯建模和ROC分析预测安慰剂反应者。
Br J Clin Pharmacol. 2007 May;63(5):595-613. doi: 10.1111/j.1365-2125.2006.02815.x.
7
Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents.心理治疗与抗抑郁药物单独及联合使用治疗儿童和青少年抑郁症
Cochrane Database Syst Rev. 2012 Nov 14;11:CD008324. doi: 10.1002/14651858.CD008324.pub2.
8
Placebo response and antidepressant clinical trial outcome.安慰剂反应与抗抑郁药物临床试验结果。
J Nerv Ment Dis. 2003 Apr;191(4):211-8. doi: 10.1097/01.NMD.0000061144.16176.38.
9
REVAMP - Research Evaluating the Value of Augmenting Medication with Psychotherapy: rationale and design.REVAMP - 评估心理治疗辅助药物治疗价值的研究:原理与设计
Psychopharmacol Bull. 2008;41(4):5-33.
10
Individual Differences in Response to Antidepressants: A Meta-analysis of Placebo-Controlled Randomized Clinical Trials.抗抑郁药反应的个体差异:安慰剂对照随机临床试验的荟萃分析。
JAMA Psychiatry. 2021 May 1;78(5):490-497. doi: 10.1001/jamapsychiatry.2020.4564.

本文引用的文献

1
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.单次剂量裸盖菇素治疗难治性重度抑郁症发作。
N Engl J Med. 2022 Nov 3;387(18):1637-1648. doi: 10.1056/NEJMoa2206443.
2
Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment-resistant depression.治疗抵抗性抑郁症患者使用消旋体氯胺酮和 Esketamine 输注后抑郁症状缓解和应答的临床预测因子。
Hum Psychopharmacol. 2022 Jul;37(4):e2836. doi: 10.1002/hup.2836. Epub 2022 Feb 18.
3
Strategies to Prolong Ketamine's Efficacy in Adults with Treatment-Resistant Depression.
延长氯胺酮治疗成人抵抗性抑郁症疗效的策略。
Adv Ther. 2021 Jun;38(6):2795-2820. doi: 10.1007/s12325-021-01732-8. Epub 2021 Apr 30.
4
Does body mass index predict response to intravenous ketamine treatment in adults with major depressive and bipolar disorder? Results from the Canadian Rapid Treatment Center of Excellence.体重指数是否能预测成人重症抑郁和双相情感障碍患者静脉注射氯胺酮治疗的反应?来自加拿大快速治疗卓越中心的结果。
CNS Spectr. 2022 Jun;27(3):322-330. doi: 10.1017/S1092852920002102. Epub 2020 Dec 3.
5
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Réseau Canadien Pour Les Traitements De L'humeur Et De L'anxiété (Canmat) Concernant L'utilisation De La Kétamine Racémique Chez Les Adultes Souffrant De Trouble Dépressif Majeur.加拿大心境与焦虑治疗网络(CANMAT)成人重性抑郁障碍使用消旋卡前列甲酯治疗工作组推荐:加拿大心境与焦虑治疗网络(CANMAT)成人重性抑郁障碍使用消旋卡前列甲酯治疗工作组推荐。
Can J Psychiatry. 2021 Feb;66(2):113-125. doi: 10.1177/0706743720970860. Epub 2020 Nov 11.
6
Sleep deprivation as treatment for depression: Systematic review and meta-analysis.睡眠剥夺作为抑郁症的治疗方法:系统评价与荟萃分析。
Acta Psychiatr Scand. 2021 Jan;143(1):22-35. doi: 10.1111/acps.13253. Epub 2020 Dec 27.
7
The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder: Results from the Canadian Rapid Treatment Center of Excellence.重复静脉注射氯胺酮对伴有或不伴有双相障碍的成年重性抑郁障碍患者抑郁症状、自杀意念和功能残疾的疗效:来自加拿大快速治疗卓越中心的结果。
J Affect Disord. 2020 Sep 1;274:903-910. doi: 10.1016/j.jad.2020.05.088. Epub 2020 May 26.
8
Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression.在一项针对难治性重度抑郁症的随机、安慰剂对照、交叉试验中,氯胺酮代谢物、临床反应和γ波功率
Neuropsychopharmacology. 2020 Jul;45(8):1398-1404. doi: 10.1038/s41386-020-0663-6. Epub 2020 Apr 6.
9
Electrophysiological biomarkers of antidepressant response to ketamine in treatment-resistant depression: Gamma power and long-term potentiation.抗抑郁药反应的电生理生物标志物对治疗抵抗性抑郁症的影响:伽马功率和长时程增强。
Pharmacol Biochem Behav. 2020 Feb;189:172856. doi: 10.1016/j.pbb.2020.172856. Epub 2020 Jan 17.
10
Magnetoencephalographic Correlates of Suicidal Ideation in Major Depression.磁源性影像脑电图与重性抑郁障碍自杀意念的相关性。
Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 Mar;5(3):354-363. doi: 10.1016/j.bpsc.2019.11.011. Epub 2019 Dec 3.